Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00002076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the safety and effectiveness of fluconazole as treatment for acute cryptococcal meningitis in AIDS patients. Both newly diagnosed and relapsed patients are eligible.
Conditions
- Meningitis, Cryptococcal
- HIV Infections
Interventions
- DRUG
-
Fluconazole
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
NCT00002010 ·Status: COMPLETED ·Phase: NA
-
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
NCT00002074 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00002068 ·Status: COMPLETED ·Phase: NA
-
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
NCT00001017 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
NCT00002305 ·Status: COMPLETED ·Phase: NA
-
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00002075 ·Status: COMPLETED ·Phase: NA
-
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
NCT00885703 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00000708 ·Status: COMPLETED ·Phase: NA
-
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
NCT00145249 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
NCT01715922 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00000639 ·Status: COMPLETED ·Phase: NA
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
NCT00002038 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
NCT00002019 ·Status: COMPLETED ·Phase: NA
-
Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis
NCT04532463 ·Status: COMPLETED
-
Platform Trial For Cryptococcal Meningitis
NCT06666322 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome
NCT00000627 ·Status: COMPLETED ·Phase: NA
-
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
NCT00000676 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NCT00002277 ·Status: COMPLETED ·Phase: PHASE3
-
Operational Research for Cryptococcal Antigen Screening
NCT01535469 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis
NCT06414512 ·Status: COMPLETED ·Phase: PHASE2
-
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
NCT04031833 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
NCT00000744 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection
NCT01562132 ·Status: TERMINATED ·Phase: PHASE2
-
Three Induction Treatments on Cryptococcal Meningitis
NCT04072640 ·Status: UNKNOWN ·Phase: EARLY_PHASE1